Caffeine as an opioid analgesic adjuvant in fibromyalgia

References

• FredholmBBBättigKHolménJNehligAZvartauEEActions of caffeine in the brain with special reference to factors that contribute to its widespread usePharmacol Rev19995118313310049999
   PubMed Web of Science ®Google Scholar
• SomogyiLCaffeine Intake by the U.S. Population2010 Available from: http://www.fda.gov/downloads/AboutFDA/CentersOffices/Officeof-Foods/CFSAN/CFSANFOIAElectronicReadingRoom/UCM333191.pdfAccessed August 7, 2014
   Google Scholar
• McCallALMillingtonWRWurtmanRJBlood-brain barrier transport of caffeine: Dose-related restriction of adenine transportLife Sci19823124270927157154859
   PubMed Web of Science ®Google Scholar
• GladeMJCaffeine-not just a stimulantNutrition2010261093293820888549
   PubMed Web of Science ®Google Scholar
• QuinlanPLaneJAspinallLEffects of hot tea, coffee and water ingestion on physiological responses and mood: the role of caffeine, water and beverage typePsychopharmacology (Berl)199713421641739399380
   PubMed Web of Science ®Google Scholar
• AddicottMAYangLLPeifferAMThe effect of daily caffeine use on cerebral blood flow: how2010301031023114
   Google Scholar
• LaskaEMSunshineAMuellerFElversWBSiegelCRubinACaffeine as an analgesic adjuvantJAMA198425113171117186366275
   PubMed Web of Science ®Google Scholar
• MigliardiJRArmellinoJJFriedmanMGillingsDBBeaverWTCaffeine as an analgesic adjuvant in tension headacheClin Pharmacol Ther19945655765867955822
   PubMed Web of Science ®Google Scholar
• DerryCJDerrySMooreRACaffeine as an analgesic adjuvant for acute pain in adults (Review)Cochrane Database Syst Rev20123CD0092981
   Web of Science ®Google Scholar
• SawynokJMethylxanthines and painFredholmBHandbook of Experimental Pharmacology 200Berlin, HeidelbergSpringer-Verlag Berlin Heidelberg2011311329
   Google Scholar
• GoldmanNChenMFujitaTAdenosine A1 receptors mediate local anti-nociceptive effects of acupunctureNat Neurosci201013788388820512135
   PubMed Web of Science ®Google Scholar
• BurnstockGSawynokJAdenosine triphosphate and adenosine receptors and painPharmacol Pain1985 Available from: http://www-ucl-slb.ucl.ac.uk/ani/GB-s%20PDF%20file%20copies/CV1419.pdfAccessed February 10, 2017
   Google Scholar
• Abo-salemOHayallahABilkei-GorzoAFilipekBZimmerAMullerCAntinociceptive effects of novel A2B adenosine receptor antagonistsJ Pharmcology Exp Ther20043081358366
   Web of Science ®Google Scholar
• FredholmBBAstra Award Lecture. Adenosine, adenosine receptors and the actions of caffeinePharmacol Toxicol1995762931017746802
   PubMedGoogle Scholar
• SawynokJYakshTLCaffeine as an analgesic adjuvant : a review of pharmacology and mechanisms of actionPharmacol Rev199345143858475169
   PubMed Web of Science ®Google Scholar
• NascimentoFPMacedoSJSantosAThe involvement of purinergic system in pain : adenosine receptors and inosine as pharmacological tools in future treatmentsGallelliLPharmacologyCroatiaInTech2012627650
   Google Scholar
• SawynokJAdenosine ReceptorsCairnsBEPeripheral Receptor Targets for Analgesia: Novel Approaches to Pain ManagementNew Jersey, USAJohn Wiley and Sons, Inc2009137152
   Google Scholar
• MoréAOCidral-FilhoFJMazzardo-MartinsLCaffeine at moderate doses can inhibit acupuncture-induced analgesia in a mouse model of postoperative painJ Caffeine Res20133314314824761281
   PubMedGoogle Scholar
• SawynokJReidARCaffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting spinal adenosine A1 receptorsEur J Pharmacol20126742–324825422085758
   PubMed Web of Science ®Google Scholar
• SawynokJAdenosine receptor activation and nociceptionEur J Pharmacol199834711119650842
   PubMed Web of Science ®Google Scholar
• WuWPHaoJXHalldner-HenrikssonLDecreased inflammatory pain due to reduced carrageenan-induced inflammation in mice lacking adenosine A3 receptorsNeuroscience2002114352352712220556
   PubMed Web of Science ®Google Scholar
• ChenZJanesKChenCControlling murine and rat chronic pain through A3 adenosine receptor activationFASEB J20122651855186522345405
   PubMed Web of Science ®Google Scholar
• JanesKEspositoEDoyleTA3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathwaysPain2014155122560256725242567
   PubMed Web of Science ®Google Scholar
• SawynokJAdenosine receptor targets for painNeuroscience201633811826500181
   PubMed Web of Science ®Google Scholar
• LittleJWFordASymons-LiguoriAMEndogenous adenosine A3 receptor activation selectively alleviates persistent pain statesBrain20151381283525414036
   PubMed Web of Science ®Google Scholar
• SawynokJPharmacological rationale for the clinical use of caffeineDrugs199549137507705215
   PubMed Web of Science ®Google Scholar
• ClauwDJFibromyalgia: a clinical reviewJAMA2014311151547155524737367
   PubMed Web of Science ®Google Scholar
• HassettALWassermanRGoeslingJRakovitisKShiBBrummettCMLongitudinal assessment of pain outcomes in the clinical setting: development of the “APOLO” electronic data capture systemReg Anesth Pain Med201237439840222653521
   PubMed Web of Science ®Google Scholar
• GoeslingJBrummettCMHassettALCigarette smoking and pain: depressive symptoms mediate smoking-related pain symptomsPain201215381749175422703693
   PubMed Web of Science ®Google Scholar
• HassettALHilliardPEGoeslingJClauwDJHarteSEBrummettCMReports of chronic pain in childhood and adolescence among patients at a tertiary care pain clinicJ Pain201314111390139724021576
   PubMed Web of Science ®Google Scholar
• WassermanRABrummettCMGoeslingJTsodikovAHassettALCharacteristics of chronic pain patients who take opioids and persistently report high pain intensityReg Anesth Pain Med2014391131724310048
   PubMed Web of Science ®Google Scholar
• BrummettCMJandaAMSchuellerCMSurvey Criteria for fibromyalgia independently predict increased postoperative opioid consumption after lower-extremity joint arthroplastyAnesthesiology201311961434144324343289
   PubMed Web of Science ®Google Scholar
• WolfeFClauwDFitzcharlesMAFibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for FibromyalgiaJ Rheumatol20113861113112221285161
   PubMed Web of Science ®Google Scholar
• KellerSBannCMDoddSLScheinJMendozaTRCleelandCSValidity of the brief pain inventory for use in documenting the outcomes of patients with noncancer painClin J Pain200420530931815322437
   PubMed Web of Science ®Google Scholar
• SchaletBDHaysRDJensenSEBeaumontJLFriesJFCellaDValidity of PROMIS physical function measured in diverse clinical samplesJ Clin Epidemiol20167311211826970039
   PubMed Web of Science ®Google Scholar
• ZigmondASSnaithRPThe hospital anxiety and depression scaleActa Psychiatr Scand19836763613706880820
   PubMed Web of Science ®Google Scholar
• RosenstielAKKeefeFJThe use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustmentPain198317133446226916
   PubMed Web of Science ®Google Scholar
• WatsonDClarkLATellegenADevelopment and validation of brief measures of positive and negative affect: the PANAS scalesJ Pers Soc Psychol1988546106310703397865
   PubMed Web of Science ®Google Scholar
• McPartlandJMMitchellJACaffeine and chronic back painArch Phys Med Rehabil199778161639014959
   PubMed Web of Science ®Google Scholar
• CurrieSRWilsonKGGauthierSTCaffeine and chronic low back painClin J Pain19951132142198535041
   PubMed Web of Science ®Google Scholar
• MercadanteSSerrettaRCasuccioAEffects of caffeine as an adjuvant to morphine in advanced cancer patients. A randomized, double-blind, placebo-controlled, crossover studyJ Pain Symptom Manage200121536937211369156
   PubMed Web of Science ®Google Scholar
• SuhSYChoiYSOhSCCaffeine as an adjuvant therapy to opioids in cancer pain: a randomized, double-blind, placebo-controlled trialJ Pain Symptom Manage201346447448223498965
   PubMed Web of Science ®Google Scholar
• Carrillo-munguíaNGonzález-trujanoMEHuertaMTrujilloXDíaz-revalMITramadol and tramadol + caffeine synergism in the rat formalin test are mediated by central opioid and serotonergic mechanismsBiomed Res Int2015201568642426146627
   PubMed Web of Science ®Google Scholar
• MalecDMichalskaEThe effect of methylxanthines on morphine analgesia in mice and ratsPol J Pharmacol Pharm19884032232323241763
   PubMedGoogle Scholar
• MisraALPontaniRBVadlamaniNLPotentiation of morphine analgesia by caffeineBr J Pharmacol19858447897914005485
   PubMed Web of Science ®Google Scholar
• PersonDLKissinIBrownPTVinikHRBradleyELMorphine–caffeine analgesic interaction in ratsAnesth Analg19856498518564025851
   PubMed Web of Science ®Google Scholar
• HutchinsonDHoVDoddMDawsonHNZumwaltACColtonCAPain, nicotine, and smoking: research findings and mechanistic considerationsPsychol Bull201113761065109321967450
   PubMed Web of Science ®Google Scholar
• ArnoldMACarrDBTogasakiDMPianMCMartinJBCaffeine stimulates beta-endorphin release in blood but not in cerebrospinal fluidLife Sci19823110101710246290811
   PubMed Web of Science ®Google Scholar
• BerkowitzBATarverJHSpectorSRelease of norepinephrine in the central nervous system by theophylline and caffeineEur J Pharmacol197010164715458986
   PubMed Web of Science ®Google Scholar
• CorrodiHFuxeKJonssonGEffects of caffeine on central monoamine neuronsJ Pharm Pharmacol19722421551584401973
   PubMed Web of Science ®Google Scholar
• KuritaGPLundorffLPimentaCA de MSjøgrenPThe cognitive effects of opioids in cancer: a systematic reviewSupport Care Cancer2009171112118762994
   PubMed Web of Science ®Google Scholar
• SmithAEffects of caffeine on human behaviorFood Chem Toxicol20024091243125512204388
   PubMed Web of Science ®Google Scholar
• McLellanTMCaldwellJALiebermanHRA review of caffeine’s effects on cognitive, physical and occupational performanceNeurosci Biobehav Rev20167129431227612937
   PubMed Web of Science ®Google Scholar
• SmithACaffeine and central noradrenaline: effects on mood, cognitive performance, eye movements and cardiovascular functionJ Psychopharmacol200317328329214513920
   PubMed Web of Science ®Google Scholar